H.Res. 98 · 112th Congress

Expressing the Sense of the House of Representatives that the Commissioner of the Food and Drug Administration should give the greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural sciences, physical sciences, and computing sciences.

Stage
In committee
Introduced
2011-02-17
Latest action
2011-02-28 · Referred to the Subcommittee on Health.

Subjects

Administrative law and regulatory procedures
Health
Department of Health and Human Services
Food supply, safety, and labeling
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)